Cite
Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults
MLA
Frey, Sharon E., et al. “Comparison of the Safety and Immunogenicity of ACAM1000, ACAM2000 and Dryvax® in Healthy Vaccinia-Naive Adults.” Vaccine, vol. 27, no. 10, Mar. 2009, pp. 1637–44. EBSCOhost, https://doi.org/10.1016/j.vaccine.2008.11.079.
APA
Frey, S. E., Newman, F. K., Kennedy, J. S., Ennis, F., Abate, G., Hoft, D. F., & Monath, T. P. (2009). Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults. Vaccine, 27(10), 1637–1644. https://doi.org/10.1016/j.vaccine.2008.11.079
Chicago
Frey, Sharon E., Frances K. Newman, Jeffrey S. Kennedy, Francis Ennis, Getahun Abate, Daniel F. Hoft, and Thomas P. Monath. 2009. “Comparison of the Safety and Immunogenicity of ACAM1000, ACAM2000 and Dryvax® in Healthy Vaccinia-Naive Adults.” Vaccine 27 (10): 1637–44. doi:10.1016/j.vaccine.2008.11.079.